Literature DB >> 9201777

A multicenter study of sleep-wake rhythm disorders: therapeutic effects of vitamin B12, bright light therapy, chronotherapy and hypnotics.

H Yamadera1, K Takahashi, M Okawa.   

Abstract

One hundred and six subjects with primary sleep-wake rhythm disorders [13 non-24 hour sleep-wake syndrome (non-24), 76 delayed sleep phase syndrome (DSPS), 11 irregular sleep-wake pattern (irregular) and six long sleepers] were treated with vitamin B12, bright light, chronotherapy and/or hypnotics. These therapies caused moderate or remarkable improvement in 32% of the non-24, 42% of DSPS, 45% of irregular and 67% of long sleepers. A lack of adequate sleep, unpleasant feelings at waking and daytime drowsiness were also improved in DSPS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9201777     DOI: 10.1111/j.1440-1819.1996.tb02743.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  7 in total

Review 1.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Therapeutics for Circadian Rhythm Sleep Disorders.

Authors:  Ehren R Dodson; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2010-12

3.  Circadian Rhythm Sleep Disorder: Irregular Sleep Wake Rhythm Type.

Authors:  Phyllis C Zee; Michael V Vitiello
Journal:  Sleep Med Clin       Date:  2009-06-01

4.  Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.

Authors:  R Robert Auger; Helen J Burgess; Jonathan S Emens; Ludmila V Deriy; Sherene M Thomas; Katherine M Sharkey
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

5.  Melatonin prevents hypochlorous acid-mediated cyanocobalamin destruction and cyanogen chloride generation.

Authors:  Roohi Jeelani; Dhiman Maitra; Charalampos Chatzicharalampous; Syed Najeemuddin; Robert T Morris; Husam M Abu-Soud
Journal:  J Pineal Res       Date:  2018-01-09       Impact factor: 13.007

6.  Non-24-hour sleep-wake syndrome improved by low-dose valproic acid: a case report.

Authors:  Masatake Kurita; Takahiro Moriya; Satoshi Nishino; Eishin Hirata; Noriyasu Hirasawa; Yoshiro Okubo; Tadahiro Sato
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-13       Impact factor: 2.570

7.  Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report.

Authors:  Masahiro Takeshima; Tetsuo Shimizu; Hiroyasu Ishikawa; Takashi Kanbayashi
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.